These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7722389)

  • 1. [Physiopathology and therapy of drug-induced stomach diseases in the aged].
    Asaki S
    Nihon Naika Gakkai Zasshi; 1995 Feb; 84(2):235-40. PubMed ID: 7722389
    [No Abstract]   [Full Text] [Related]  

  • 2. [Etiological mechanism and drug-induced gastric mucosal lesions].
    Kawano S; Tsuji S; Masuda E; Kamada T
    Nihon Naika Gakkai Zasshi; 1995 Feb; 84(2):230-4. PubMed ID: 7722388
    [No Abstract]   [Full Text] [Related]  

  • 3. [Efficacy of sucralfate in the prevention of stomach diseases induced by non-steroidal anti-inflammatory drugs].
    Fioravanti A; Giordano N; Biasi G; Vaccai D; Cataldi V; Marcolongo R
    Clin Ter; 1989 Sep; 130(6):333-6. PubMed ID: 2530034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-steroidal anti-inflammatory drugs induced gastropathy: endoscopic findings in rheumatic patients.
    Rodríguez W; Irrizarry JF; Latimer C
    Bol Asoc Med P R; 1988 Oct; 80(10):366-8. PubMed ID: 3265062
    [No Abstract]   [Full Text] [Related]  

  • 5. [How to define in diagnosis endoscopically detected lesions of gastrointestinal mucosa which arose in th time of administration of nonsteroidal antiinflammatory drugs?].
    Murav'ev IuV
    Klin Med (Mosk); 2000; 78(11):61-3. PubMed ID: 11232536
    [No Abstract]   [Full Text] [Related]  

  • 6. [2-nd place of Young Scientist's Competition. Basal prostaglandins level in stomach mucous as predictors of NSAID-gastropathy].
    Kim VA
    Eksp Klin Gastroenterol; 2009; (7):114-8. PubMed ID: 20469716
    [No Abstract]   [Full Text] [Related]  

  • 7. Updates on the management of upper gastrointestinal disorders in the primary care setting: NSAID-related gastropathies and pediatric reflux diseases.
    Gold BD; Scheiman JM; Sabesin SM; Vitat P
    J Fam Pract; 2007 Mar; 56(3 Suppl Updates):S1-11; quiz S12. PubMed ID: 17343806
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytoprotection in NSAID gastropathy.
    Roth SH
    Compr Ther; 1988 Feb; 14(2):3-5. PubMed ID: 3278837
    [No Abstract]   [Full Text] [Related]  

  • 9. [Physiopathology and therapy of drug-induced intestinal diseases].
    Yao T; Matsui T
    Nihon Naika Gakkai Zasshi; 1995 Feb; 84(2):248-53. PubMed ID: 7722391
    [No Abstract]   [Full Text] [Related]  

  • 10. [Gastropathies caused by non-steroidal antirheumatic agents].
    Dítĕ P; Novotný I
    Vnitr Lek; 2002 Nov; 48(11):1075-81. PubMed ID: 12577460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsteroidal anti-inflammatory drug gastropathy. Recognition and response.
    Roth SH; Bennett RE
    Arch Intern Med; 1987 Dec; 147(12):2093-100. PubMed ID: 3318750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol.
    Koch M
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S54-62. PubMed ID: 10379471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytoprotective effect of rosaprostol during treatment with non-steroidal anti-inflammatory agents in arthrorheumatic pathologies].
    Cataldo MG; Sallì L; Scalici G; D'Aiuto A; Bongiorno A; Salerno L
    Minerva Dietol Gastroenterol; 1989; 35(3):191-4. PubMed ID: 2601868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An unusual gastrointestinal manifestation of non-steroidal anti-inflammatory drugs.
    Kekilli M; Köklü S; Beyazit Y; Arhan M; Basar O
    Dig Endosc; 2010 Jul; 22(3):251-2. PubMed ID: 20642623
    [No Abstract]   [Full Text] [Related]  

  • 15. [Gastric lesions induced by non-steroidal antiinflammatory drugs (part I)].
    Nasonov EL; Karateev AE
    Klin Med (Mosk); 2000; 78(3):4-10. PubMed ID: 10790955
    [No Abstract]   [Full Text] [Related]  

  • 16. [NSAID-gastropathy: state-of-the-art therapy optimization capabilities in outpatient practice].
    Burkov SG; Arutiunov AT; Gurova NIu; Lobanova EG; Nikiforov PA; Okoemov MN; Cherezova IN; Chugunnikova LI
    Eksp Klin Gastroenterol; 2008; (3):97-101. PubMed ID: 19145889
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of non-steroidal anti-inflammatory drugs and gastric and duodenal complications].
    de Boer SY; van Berge Henegouwen GP
    Ned Tijdschr Geneeskd; 1988 Jan; 132(4):154-7. PubMed ID: 3277072
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pathogenesis and therapy of non-steroidal anti-inflammatory drug (NSAID)-induced gastric mucosal injury].
    Yoshikawa T; Naito Y; Yoshida N
    Nihon Seikeigeka Gakkai Zasshi; 1996 May; 70(5):269-73. PubMed ID: 8727665
    [No Abstract]   [Full Text] [Related]  

  • 19. [Gastrointestinal bleeding induced by nonsteroidal antiinflammatory drugs].
    Shostak NA; Aksenova AV; Riabkova AA; Fedorov ED; Maliarova LP; Krutova TA; Dunaeva IuV; Ivanov DS; Kazakova TV
    Ter Arkh; 2000; 72(5):60-1. PubMed ID: 11109625
    [No Abstract]   [Full Text] [Related]  

  • 20. Is Helicobacter pylori infection a risk or protective factor for mucosal lesions development in patients chronically treated with acetylsalicylic acid?
    Kordecki H; Kurowski M; Kosik R; Pilecka D
    J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():85-91. PubMed ID: 9440059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.